Join the 'Gammar-P IV' group to help and get support from people like you.
Gammar-P IV News
Posted 27 Jul 2011 by Drugs.com
WEDNESDAY, July 27 – A combination therapy that "desensitizes" kidney transplant recipients could help hard-to-match patients find a needed kidney faster. The desensitization procedure combines the use of plasmapheresis – a machine that filters the blood plasma to remove antibodies – and low-doses of a medication called intravenous immune globulin (IVIG). The combination of these therapies improves survival rates dramatically. Eight years after receiving a transplant, survival rates were 81 percent for those who received the treatment compared to just 31 percent for people who had to stay on dialysis, new research found. "This is a huge unmet problem. There are probably as many as 30,000 people who have been exposed to foreign tissue waiting for a kidney. They're really hard to match," explained study author Dr. Robert Montgomery, director of the comprehensive transplant program at ... Read more
Related support groups: Renal Transplant, Gammagard, Gamunex, Immune Globulin Intravenous, Privigen, Sandoglobulin, Octagam, Carimune NF, Carimune, Flebogamma, Venoglobulin-S 5%, Gamimune N 10%, Panglobulin NF, Gammar-P IV, Venoglobulin-S 10%, Iveegam En, Gamimune, Panglobulin, Gamimune N 5%, Gammaplex
Ask a Question
Related Condition Support Groups
Chronic Lymphocytic Leukemia (CLL), Idiopathic (Immune) Thrombocytopenic Purpura, Autoimmune Neutropenia, Bone Marrow Transplantation, Primary Immunodeficiency Syndrome, Evan's Syndrome, Polymyositis / Dermatomyositis, HIV Infection, Kawasaki Disease